Calamos S&P 500 Structured Alt Protection ETF – March
New York Stock Exchange ArcaRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Calamos Investments LLC (Calamos) provides asset management services focused on alternative, equity, fixed income, convertible, multi-asset, and sustainable investment strategies through exchange-traded funds, mutual funds, closed-end funds, interval funds, UCITS funds, and separately managed accounts; its structured protection ETF suite, including the flagship Calamos S&P 500 Structured Alt Protection ETF - March (CPSR; ticker: CPSR), seeks to deliver the positive price return of the SPDR S&P 500 ETF Trust up to an annual cap (such as the 7.63% upside cap rate set at CPSR's March 3, 2025 launch) with 100% downside protection against losses over a one-year outcome period before fees and expenses, utilizing FLEX options for exposure to large-cap U.S. equities; additional offerings encompass monthly series structured protection ETFs tracking S&P 500, Nasdaq-100, Russell 2000, and Bitcoin benchmarks with varying protection levels, autocallable income ETFs like CAIE and the planned CAIQ, private credit and equity interval funds under the AC Private Markets brand, and convertibles-focused products. Founded in 1977 by John P. Calamos Sr. and headquartered in Naperville, Illinois, with offices across Chicago, New York, San Francisco, Milwaukee, Portland, Miami, and London, the firm manages over $40 billion in assets, including more than $18 billion in liquid alternatives, serving individual, institutional, and intermediary clients globally. Recent developments include the July 2025 launch of the Calamos Aksia Private Equity & Alternatives Fund (CAPVX) and AC Private Markets brand in partnership with Aksia, the October 2025 debut of Bitcoin laddered structured protection ETFs and Hedged Strategies Fund (HEDGX), the November 2025 introduction of the CAIQ Nasdaq-100 Autocallable Income ETF, ongoing cap rate resets and expansions of the structured protection series (such as CPSU, CPNJ, and CPSM), and level distribution policy adoptions for select closed-end funds.
Gelesis, Maker Of Weight Loss Pill, Concludes SPAC Deal; Trading Kickstarts Today
Gelesis®, the Maker of Plenity® for Weight Management, Will Debut as a Publicly Traded Company Following the Closing of Its Business Combination with Capstar
Gelesis Adds Inogen Co-Founder and Former CFO Ali Bauerlein to Board of Directors and Audit Committee
Have Your Cake and Eat It Too: Plenity® Creates Edible Dessert Billboard to Challenge Overly Restrictive Dieting Assumptions
Gelesis’ FDA-Cleared Weight Management Approach, Plenity®, Now Broadly Available and Leading Nutrition Authority Joy Bauer, MS, RDN, CDN, Joins as Chief Nutrition Officer
Gelesis Receives $30 Million Plenity Order from Ro
Nature’s Scientific Reports Features Gelesis’ Novel and Foundational Biomimetic Platform for Treating Obesity and Conditions Related to Diet-Induced Gut Damage
Two Senior Scientific Leaders at Gelesis Awarded Top Industry Honors
FDA-Approved Weight Loss Drug Plenity's Parent Announces SPAC Deal: What Investors Should Know
Gelesis, a Consumer-Focused Biotherapeutics Company and the Maker of Plenity®, to Become a Publicly Traded Company via Merger with Capstar Special Purpose Acquisition Corp.
Gelesis, a Consumer-Focused Biotherapeutics Company and the Maker of Plenity®, to Become a Publicly Traded Company via Merger with Capstar Special Purpose Acquisition Corp.
Capstar Special Purpose Acquisition Corp. Receives Expected Notice from NYSE Regarding Delayed Quarterly Report